Patents
Patents for C07K 19 - Hybrid peptides (29,428)
10/1999
10/12/1999US5965710 An immunoglobulin which binds human membrane-bound carcinoembryonic antigen; anticarcinogenic agent
10/12/1999US5965535 Isolated human leukocyte antigen (hla) class ii-binding peptide and amino sequence encoding it; the peptides stimulate the activity and proliferation of cd4+ t lymphocytes
10/12/1999US5965390 Protein L and hybrid proteins thereof
10/12/1999US5965383 Fibrin binding domain polypeptides and uses and methods of producing same
10/12/1999US5965373 Identifying enzyme inhibitors by combining a dimeric protein with a substrate, and a compound believed to be an inhibitor and determining activity of the protein on the substrate; diagnosis of epithelial cancer
10/07/1999WO1999050302A1 Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production
10/07/1999WO1999049892A2 Use of active p40 conjugates for nasal delivery
10/07/1999WO1999023221A3 Multivalent antigen-binding proteins
10/07/1999CA2324477A1 Use of active p40 conjugates for nasal delivery
10/06/1999EP0946736A1 Method for expression of heterologous proteins in yeast
10/06/1999EP0946715A1 Modified protein c and methods of use thereof
10/06/1999CN1230966A Use of leptin antagonists for treating insulin resistance in type II diabetes
10/05/1999US5962289 Polysaccharide binding fusion proteins and conjugates
10/05/1999US5962236 Immunoassay using antibodies against free lysyl pyridinoline cross-links in unhydrolyzed urine sample
10/05/1999CA1340776C Multispecific antigenic proteins
10/01/1999CA2249043A1 Novel compounds
09/1999
09/30/1999WO1999049061A1 Kinase wee1 fusion protein compositions, nucleotide sequences, expression systems, and methods of use
09/30/1999WO1999049039A2 GFRα3 AND ITS USES
09/30/1999WO1999048918A1 Protease conjugates
09/30/1999WO1999048915A1 Orphan nuclear receptor
09/30/1999WO1999041383A8 Antigen library immunization
09/30/1999CA2324506A1 Protease conjugates
09/30/1999CA2324230A1 Kinase wee1 fusion protein compositions, nucleotide sequences, expression systems, and methods of use
09/29/1999EP0944723A2 Mammalian chemokines
09/29/1999EP0944720A1 Adaptor protein frs2 and related products and methods
09/29/1999EP0474645B1 Protein complex
09/29/1999CN1230220A Therapy for 'alpha'-galactosidase deficiency
09/29/1999CN1230198A Therapeutic multispecific compounds comprised of anti-FC'alpha' receptor antibodies
09/29/1999CN1229799A Gene engineering immune toxin of anti-carcinoma of bladder and its prodn. process
09/28/1999US5959176 Plant promoter and utilization thereof
09/28/1999US5959083 Tetravalent bispecific receptors, the preparation and use thereof
09/28/1999US5959079 CREBA isoform
09/28/1999US5958424 Recombinant chicken anemia virus particle
09/28/1999US5958415 Protein allergen of Derf II and composition
09/28/1999CA2088354C Pancreas-elastasis-1-specific antibody, a process for obtaining it and a test kit containing such antibodies
09/28/1999CA2076678C Improved chimeric toxins
09/28/1999CA2072095C Outer membrane protein p1 and peptides of haemophilus influenzae type b
09/23/1999WO1999047677A2 Polypeptides homologous to vegf and bmp1
09/23/1999WO1999047151A1 Peptide ligands for the erythropoietin receptor
09/23/1999WO1999032620A9 Insulin-like growth factor binding protein fragments and the utilization thereof
09/23/1999CA2263784A1 Dual-tagged proteins and their uses
09/22/1999EP0943683A1 Human vanilloid receptor homologue Vanilrep1
09/22/1999EP0942998A1 Notch
09/22/1999EP0942984A2 C3 BINDING PROTEIN OF $i(STREPTOCOCCUS PNEUMONIAE)
09/22/1999EP0942973A1 Mutants of the lag-3 proteins, products for the expression of these mutants and use
09/22/1999EP0942758A2 Compounds with improved inductive effect on cartilage and bones
09/22/1999EP0620741B1 Cytotoxic drug therapy
09/22/1999CN1229439A Fusion polypeptides comprising an IgE-binding domain and a HSA component, and their diagnostic and therapeutic uses
09/22/1999CN1229087A Insect-resistance fusion protein, its coded gene and method for producing transgenosis strain using said gene
09/21/1999US5955580 Vaccines for nontypable haemophilus influenzae
09/21/1999US5955358 Adjusting nucleic acids to increase binding of encoded antibody by randomly incorporating complementarity determining regions; enhancing immune response
09/21/1999US5955300 Immunoglobulin fusion protein with amino acid replacements immunosuppressant against autoimmune diseases; useful in the therapeutic treament of melanomas and leukemias
09/21/1999US5955260 Antibodies that bind viral proteins that share homogeneity; for diagnostic immunoassay of virus in sample
09/21/1999US5955090 Immunogenic hybrid protein OprF-OprI derived from Pseudomonas aeruginosa membrane proteins
09/21/1999US5955087 Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation
09/21/1999US5955073 Selective RNase cytotoxic reagents
09/16/1999WO1999046389A1 Recombinant onconase, and chemical conjugates and fusion proteins of recombinant onconase
09/16/1999WO1999046379A2 Human receptor proteins; related reagents and methods
09/16/1999WO1999046286A2 Assays and reagents for identifying anti-fungal agents, and uses related thereto
09/16/1999WO1999046281A2 Novel polypeptides and nucleic acids encoding the same
09/16/1999WO1999046274A1 Modified factor viii
09/16/1999WO1999038967A3 Recombinant proteins derived from hgf and msp
09/16/1999WO1999033868A3 Human papillomavirus vaccine
09/16/1999WO1999029878A3 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system
09/16/1999WO1996012802A9 Vaccine and antitoxin for treatment and prevention of c. difficile disease
09/16/1999CA2588590A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
09/16/1999CA2587736A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
09/16/1999CA2421394A1 Novel polypeptides and nucleic acids encoding the same
09/16/1999CA2421388A1 Novel poypeptides and nucleic acids encoding the same
09/16/1999CA2421375A1 Novel polypeptides and nucleic acids encoding the same
09/16/1999CA2421372A1 Novel polypeptides and nucleic acids encoding the same
09/16/1999CA2421364A1 Novel polypeptides and nucleic acids encoding the same
09/16/1999CA2421345A1 Novel polypeptides and nucleic acids encoding the same
09/16/1999CA2421333A1 Pro 351 polypeptides and nucleic acids encoding the same
09/16/1999CA2421329A1 Novel polypeptides and nucleic acids encoding the same
09/16/1999CA2421322A1 Pro703 polypeptides and nucleic acids encoding the same
09/16/1999CA2421319A1 Novel polypeptides and nucleic acids encoding the same
09/16/1999CA2421315A1 Novel polypeptides and nucleic acids encoding the same
09/16/1999CA2421286A1 Novel polypeptides and nucleic acids encoding the same
09/16/1999CA2421278A1 Novel polypeptides and nucleic acids encoding the same
09/16/1999CA2323631A1 Recombinant onconase, and chemical conjugates and fusion proteins of recombinant onconase
09/16/1999CA2323236A1 Human receptor proteins; related reagents and methods
09/16/1999CA2322662A1 Assays and reagents for identifying anti-fungal agents, and uses related thereto
09/16/1999CA2322508A1 Modified factor viii
09/16/1999CA2321677A1 Novel polypeptides and nucleic acids encoding the same which are useful for treating inner ear diseases
09/15/1999EP0941346A1 Secretory immunoglobulin a as a mucosal vaccine delivery system
09/15/1999EP0941334A2 Protease-activatable pseudomonas exotoxin a-like proproteins
09/15/1999EP0941322A2 Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation
09/15/1999EP0941315A1 Immune responses using compositions containing stress proteins
09/15/1999EP0851874B1 Novel variants of green fluorescent protein, gfp
09/15/1999EP0776335A4 Regulatable elimination of gene expression, gene product function and engineered host cells
09/15/1999EP0567470B1 Pseudomonas peptide composition and method for producing the same
09/14/1999US5952472 Anti-fibroblast growth factor-8 monoclonal antibody
09/14/1999US5952199 A protein that contains an immunoglobulin-like domain; antiproliferative/antitumor agents, treatment of rheumatoid arthritis, psoriasis, diabeties, glaucoma, muscular disorders and immune rejection of eye transplants
09/14/1999CA1340747C Hiv-2 virus variants
09/14/1999CA1340741C Cloned genes encoding ig-cd4 fusion protiens and the use thereof
09/14/1999CA1340735C Htlv-iii envelope peptides
09/10/1999WO1999045132A1 Poly zinc finger proteins with improved linkers
09/10/1999WO1999045119A2 Production of mycobacterial polypeptides by lactic acid bacteria
09/10/1999WO1999025829A3 Cdk2 protein and cdk2 protein complexes